// App-Quantinova.ai

581 : Bone marrow-derived B-cell hybridomas from neuroblastoma patients generate antibodies that bind to patients own tumors

Researchers

Presenter

  • Girja S. Shukla

Principal Investigators

  • Giselle S. Sholler

  • Yujing Sun

  • Stephanie C. Pero

  • Chelsea L. Carman

  • Ping Zhao

  • David N. Krag

Medical Centers

  • University of Vermont College of Medicine, South Burlington, VT

  • Helen DeVos Children's Hospital and Michigan State University, Grand Rapids, MI.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Neuroblastoma

  • Breast cancer

  • Plasmacytoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • aminopterin

  • Trastuzumab

  • Bevacizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved